These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1362697)

  • 1. Mechanisms in B-Cell Neoplasia 1992. Workshop. Bethesda, Maryland, April 21-23, 1992.
    Curr Top Microbiol Immunol; 1992; 182():1-499. PubMed ID: 1362697
    [No Abstract]   [Full Text] [Related]  

  • 2. B1 Lymphocytes in B Cell Neoplasia. Proceedings of the 16th Workshop on the Mechanisms of B Cell Neoplasia. Bethesda, Maryland, USA. October 28-29, 1999.
    Curr Top Microbiol Immunol; 2000; 252():V-XIII, 1-326. PubMed ID: 11214586
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms in B-cell neoplasia. A workshop. March 28-30, Bethesda, Maryland.
    Curr Top Microbiol Immunol; 1990; 166():1-380. PubMed ID: 2073787
    [No Abstract]   [Full Text] [Related]  

  • 4. 12th workshop on mechanisms in B-cell neoplasia. Bethesda, Maryland, April 18-20, 1994. Proceedings.
    Curr Top Microbiol Immunol; 1995; 194():1-458. PubMed ID: 7895483
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphocyte Hybridomas. Second workshop on "functional properties of tumors of T and B lymphocytes" sponsored by the National Cancer Institute (NIH) April 3--5, 1978 Bethesda, Maryland, U.S.A.
    Curr Top Microbiol Immunol; 1978; 81():preceeds IX. PubMed ID: 308432
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms in B-cell neoplasia. Workshop at the National Cancer Institute, National Institutes of Health. Bethesda, MD, USA, March 24-26, 1986.
    Curr Top Microbiol Immunol; 1986; 132():1-374. PubMed ID: 3491730
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms in B-cell neoplasia. Workshop at the National Cancer Institute, National Institutes of Health, Bethesda, MD, USA, March 23-25, 1988. Proceedings.
    Curr Top Microbiol Immunol; 1988; 141():1-340. PubMed ID: 3265084
    [No Abstract]   [Full Text] [Related]  

  • 8. Oncogenes in B-cell neoplasia. Workshop at the National Cancer Institute, National Institutes of Health, Bethesda, MD, USA, March 5-7,1984.
    Curr Top Microbiol Immunol; 1984; 113():1-268. PubMed ID: 6332708
    [No Abstract]   [Full Text] [Related]  

  • 9. Positive and negative functions of B lymphocytes in tumors.
    Shen M; Sun Q; Wang J; Pan W; Ren X
    Oncotarget; 2016 Aug; 7(34):55828-55839. PubMed ID: 27331871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Which future for B lymphocytes infiltrating solid tumors: prognostic biomarker and/or therapeutic target?].
    Kaplon H; Dieu-Nosjean MC
    Med Sci (Paris); 2018 Jan; 34(1):72-78. PubMed ID: 29384099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular perspective: antibodies.
    Goodsell DS
    Oncologist; 2001; 6(6):547-8. PubMed ID: 11743216
    [No Abstract]   [Full Text] [Related]  

  • 12. Natural killer cells in cancer.
    Höglund P; Klein E
    Semin Cancer Biol; 2006 Oct; 16(5):331-2. PubMed ID: 16931040
    [No Abstract]   [Full Text] [Related]  

  • 13. B-cell neoplasia in a developmental framework.
    Klein G
    Int J Dev Biol; 1995 Oct; 39(5):713-8. PubMed ID: 8645555
    [No Abstract]   [Full Text] [Related]  

  • 14. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. Developed and approved at the National Cancer Institute Workshop, Bethesda, Maryland, U.S.A., December 12-13, 1988.
    Acta Cytol; 1989; 33(5):567-74. PubMed ID: 2781957
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological enhancement of primary tumor development and its prevention.
    Schreiber H; Wu TH; Nachman J; Rowley DA
    Semin Cancer Biol; 2000 Oct; 10(5):351-7. PubMed ID: 11100883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathobiology of lymphocyte interactions.
    Sherwin RP; Richters A
    Pathol Annu; 1973; 8():379-406. PubMed ID: 4583017
    [No Abstract]   [Full Text] [Related]  

  • 17. Human lymphocyte subpopulations and metastatic neoplasia.
    Fudenberg HH; Smith CL
    N Engl J Med; 1977 Jul; 297(3):162-3. PubMed ID: 325415
    [No Abstract]   [Full Text] [Related]  

  • 18. APRIL in B-cell malignancies and autoimmunity.
    Kimberley FC; Medema JP; Hahne M
    Results Probl Cell Differ; 2009; 49():161-82. PubMed ID: 19142624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic intraepithelial neoplasia: significance and correlation with prostate-specific antigen and transrectal ultrasound. Proceedings of a workshop of the National Prostate Cancer Detection Project. March 13, 1989, Bethesda, Maryland.
    Urology; 1989 Dec; 34(6 Suppl):2-69. PubMed ID: 2481359
    [No Abstract]   [Full Text] [Related]  

  • 20. DEHP [Di(2-ethylhexyl)phthalate]--risk assessment. The EPA workshop. April 19-20, 1988, Bethesda, Maryland. Proceedings.
    Drug Metab Rev; 1989; 21(1):1-120. PubMed ID: 2625122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.